<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://me-pedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lyhung</id>
	<title>MEpedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://me-pedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lyhung"/>
	<link rel="alternate" type="text/html" href="https://me-pedia.org/wiki/Special:Contributions/Lyhung"/>
	<updated>2026-04-07T18:02:42Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Sodium&amp;diff=112767</id>
		<title>Sodium</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Sodium&amp;diff=112767"/>
		<updated>2022-09-29T14:35:28Z</updated>

		<summary type="html">&lt;p&gt;Lyhung:removed duplicated &amp;#039;in the&amp;#039;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Stub}}&lt;br /&gt;
&lt;br /&gt;
{{NeedsImage}}&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Sodium&#039;&#039;&#039; (chemical symbol &#039;&#039;Na&#039;&#039;) is an [[electrolyte]]. Sodium is used in many bodily processes, and has an important role in muscle and nerve function.&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite news|url=https://medlineplus.gov/sodium.html|title=Sodium: MedlinePlus|access-date=2018-10-09|language=en}}&amp;lt;/ref&amp;gt; The electrolytes sodium, potassium and magnesium have important roles in [[ion transportation]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.merriam-webster.com/dictionary/electrolyte#medicalDictionary|title=Definition of ELECTROLYTE|website=Merrian-Webster Dictionary|language=en|access-date=2018-10-09}}&amp;lt;/ref&amp;gt;Sodium is lost from the body in sweat and urine. Sodium is often consumed in the form of salt (sodium chloride), and plays an important role in blood pressure.&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[Electrolyte]]&lt;br /&gt;
&lt;br /&gt;
* [[Postural orthostatic tachycardia syndrome|Postural Orthostatic Tachycardia Syndrome]] (POTS)&lt;br /&gt;
&lt;br /&gt;
* [[Magnesium]]&lt;br /&gt;
&lt;br /&gt;
* [[Potassium]]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://lpi.oregonstate.edu/mic/minerals/sodium Linus Pauling Institute Micronutrient Information Center - Sodium (Chloride)]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Nutrients]]&lt;br /&gt;
[[Category:Minerals]]&lt;br /&gt;
[[Category:Chemical elements]]&lt;br /&gt;
[[Category:Electrolytes]]&lt;/div&gt;</summary>
		<author><name>Lyhung</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cinnarizine&amp;diff=112719</id>
		<title>Cinnarizine</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cinnarizine&amp;diff=112719"/>
		<updated>2022-09-22T11:57:48Z</updated>

		<summary type="html">&lt;p&gt;Lyhung:Copied content from Cinnarazine&amp;#039;s page (wrong name) to this page of correct name.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{DISPLAYTITLE:Cinnarizine}}&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cinnarizine&#039;&#039;&#039; is an [[antihistamine]] and [[:Category:Calcium channel blockers|calcium channel]] blocker of the diphenylmethylpiperazine group.&amp;lt;ref name=&amp;quot;DrugBank&amp;quot;&amp;gt;{{Cite web|url=https://go.drugbank.com/drugs/DB00568 |title=Cinnarizine|website= DrugBank Online|access-date=2022-04-13}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
==Potential uses==&lt;br /&gt;
Cinnarizine is typically used for [[vertigo]]/[[Ménière&#039;s disease]], vestibular conditions, [[tinnitus]], [[nystagmus]], motion sickness, [[nausea]] and [[vomiting]].&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt; Cinnarizine relaxes the blood vessels; when used together with a nootropic, such as [[piracetam]], it improves [[cerebral blood flow|blood flow to the brain]].&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Pharmacodynamics==&lt;br /&gt;
Cinnarizine has also known to have antiserotoninergic and antidopaminergic effects.&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Kariya&amp;quot;&amp;gt;{{cite journal | vauthors = Kariya S, Isozaki S, Masubuchi Y, Suzuki T, Narimatsu S | title = Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine | journal = Biochemical Pharmacology | volume = 50 | issue = 10 | pages = 1645–50 | date = November 1995 | pmid = 7503767 | doi = 10.1016/0006-2952(95)02057-8 }}&amp;lt;/ref&amp;gt; Cinnarizine blocks muscarinic acetylcholine receptors, meaning it acts against vomiting.&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The half-maximal inhibitory concentration of cinnarizine for smooth muscle contraction inhibition is 60mM.&amp;lt;ref&amp;gt;{{cite journal | vauthors = Silver PJ, Dachiw J, Ambrose JM, Pinto PB | title = Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 234 | issue = 3 | pages = 629–35 | date = September 1985 | pmid = 3162016 }}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite journal | vauthors = López MG, Moro MA, Castillo CF, Artalejo CR, García AG | title = Variable, voltage-dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion | journal = British Journal of Pharmacology | volume = 96 | issue = 3 | pages = 725–31 | date = March 1989 | pmid = 2720300 | pmc = 1854390 | doi = 10.1111/j.1476-5381.1989.tb11874.x }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Action of cinnarizine !! Target of action&lt;br /&gt;
|-&lt;br /&gt;
| Calcium ion channel antagonist || [[T-type calcium channel]]s&lt;br /&gt;
|-&lt;br /&gt;
| Antihistaminic || [[H1 receptor]]s&lt;br /&gt;
|-&lt;br /&gt;
| Antiserotinergic || [[5-HT2 receptor|5-HT&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; receptor]]s&amp;lt;ref&amp;gt;{{cite journal | vauthors = Pukhal&#039;skaya TG, Kolosova OA, Men&#039;shikov MY, Vein AM | title = Effects of calcium antagonists on serotonin-dependent aggregation and serotonin transport in platelets of patients with migraine | journal = Bulletin of Experimental Biology and Medicine | volume = 130 | issue = 7 | pages = 633–5 | date = July 2000 | pmid = 11140571 | doi = 10.1007/BF02682090 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Antidopaminergic || [[D2 receptor]]s&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Costs and availability==&lt;br /&gt;
It is not available in the [[United States]] or [[Canada]].{{Citation needed|date=2022}}&lt;br /&gt;
&lt;br /&gt;
==See also ==&lt;br /&gt;
*[[Allergy]]&lt;br /&gt;
*[[Histamine]]&lt;br /&gt;
*[[Vertigo]]&lt;br /&gt;
*[[Ménière&#039;s disease]]&lt;br /&gt;
*[[Channelopathy]]&lt;br /&gt;
&lt;br /&gt;
==Learn more ==&lt;br /&gt;
*[https://go.drugbank.com/drugs/DB00568 Cinnarizine] - DrugBank Online &lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Calcium channel blockers]]&lt;br /&gt;
[[Category:Antihistamines]]&lt;br /&gt;
[[Category:H1 antihistamines]]&lt;br /&gt;
[[Category:Antiemetics]]&lt;/div&gt;</summary>
		<author><name>Lyhung</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cinnarazine&amp;diff=112718</id>
		<title>Cinnarazine</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cinnarazine&amp;diff=112718"/>
		<updated>2022-09-22T11:50:38Z</updated>

		<summary type="html">&lt;p&gt;Lyhung:Title correction (Cinnarazine -&amp;gt; Cinnarizine)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{DISPLAYTITLE:Cinnarizine}}&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cinnarizine&#039;&#039;&#039; is an [[antihistamine]] and [[:Category:Calcium channel blockers|calcium channel]] blocker of the diphenylmethylpiperazine group.&amp;lt;ref name=&amp;quot;DrugBank&amp;quot;&amp;gt;{{Cite web|url=https://go.drugbank.com/drugs/DB00568 |title=Cinnarizine|website= DrugBank Online|access-date=2022-04-13}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
==Potential uses==&lt;br /&gt;
Cinnarizine is typically used for [[vertigo]]/[[Ménière&#039;s disease]], vestibular conditions, [[tinnitus]], [[nystagmus]], motion sickness, [[nausea]] and [[vomiting]].&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt; Cinnarizine relaxes the blood vessels; when used together with a nootropic, such as [[piracetam]], it improves [[cerebral blood flow|blood flow to the brain]].&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Pharmacodynamics==&lt;br /&gt;
Cinnarizine has also known to have antiserotoninergic and antidopaminergic effects.&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Kariya&amp;quot;&amp;gt;{{cite journal | vauthors = Kariya S, Isozaki S, Masubuchi Y, Suzuki T, Narimatsu S | title = Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine | journal = Biochemical Pharmacology | volume = 50 | issue = 10 | pages = 1645–50 | date = November 1995 | pmid = 7503767 | doi = 10.1016/0006-2952(95)02057-8 }}&amp;lt;/ref&amp;gt; Cinnarizine blocks muscarinic acetylcholine receptors, meaning it acts against vomiting.&amp;lt;ref name=&amp;quot;DrugBank&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The half-maximal inhibitory concentration of cinnarizine for smooth muscle contraction inhibition is 60mM.&amp;lt;ref&amp;gt;{{cite journal | vauthors = Silver PJ, Dachiw J, Ambrose JM, Pinto PB | title = Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 234 | issue = 3 | pages = 629–35 | date = September 1985 | pmid = 3162016 }}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite journal | vauthors = López MG, Moro MA, Castillo CF, Artalejo CR, García AG | title = Variable, voltage-dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion | journal = British Journal of Pharmacology | volume = 96 | issue = 3 | pages = 725–31 | date = March 1989 | pmid = 2720300 | pmc = 1854390 | doi = 10.1111/j.1476-5381.1989.tb11874.x }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Action of cinnarizine !! Target of action&lt;br /&gt;
|-&lt;br /&gt;
| Calcium ion channel antagonist || [[T-type calcium channel]]s&lt;br /&gt;
|-&lt;br /&gt;
| Antihistaminic || [[H1 receptor]]s&lt;br /&gt;
|-&lt;br /&gt;
| Antiserotinergic || [[5-HT2 receptor|5-HT&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; receptor]]s&amp;lt;ref&amp;gt;{{cite journal | vauthors = Pukhal&#039;skaya TG, Kolosova OA, Men&#039;shikov MY, Vein AM | title = Effects of calcium antagonists on serotonin-dependent aggregation and serotonin transport in platelets of patients with migraine | journal = Bulletin of Experimental Biology and Medicine | volume = 130 | issue = 7 | pages = 633–5 | date = July 2000 | pmid = 11140571 | doi = 10.1007/BF02682090 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Antidopaminergic || [[D2 receptor]]s&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Costs and availability==&lt;br /&gt;
It is not available in the [[United States]] or [[Canada]].{{Citation needed|date=2022}}&lt;br /&gt;
&lt;br /&gt;
==See also ==&lt;br /&gt;
*[[Allergy]]&lt;br /&gt;
*[[Histamine]]&lt;br /&gt;
*[[Vertigo]]&lt;br /&gt;
*[[Ménière&#039;s disease]]&lt;br /&gt;
*[[Channelopathy]]&lt;br /&gt;
&lt;br /&gt;
==Learn more ==&lt;br /&gt;
*[https://go.drugbank.com/drugs/DB00568 Cinnarizine] - DrugBank Online &lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Calcium channel blockers]]&lt;br /&gt;
[[Category:Antihistamines]]&lt;br /&gt;
[[Category:H1 antihistamines]]&lt;br /&gt;
[[Category:Antiemetics]]&lt;/div&gt;</summary>
		<author><name>Lyhung</name></author>
	</entry>
</feed>